In silico drug repurposing for filarial infection predicts nilotinib and paritaprevir as potential inhibitors of the Wolbachia 5′-aminolevulinic acid synthase
Abstract Filarial infections affect millions of individuals and are responsible for some notorious disabilities. Current treatment options involve repeated mass drug administrations, which have been met with several challenges despite some successes. Administration of doxycycline, an anti-Wolbachia...
Enregistré dans:
Auteurs principaux: | Alexander Kwarteng, Ebenezer Asiedu, Augustina Sylverken, Amma Larbi, Yusif Mubarik, Charles Apprey |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d02960175f9b4a74b0a1ae54fbe1f403 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
New insights into the evolution of Wolbachia infections in filarial nematodes inferred from a large range of screened species.
par: Emanuele Ferri, et autres
Publié: (2011) -
Spotlight on nilotinib in the treatment of chronic myelogenous leukemia
par: Harnicar S, et autres
Publié: (2014) -
ACTIVITY OF AMINOLEVULINATE SYNTHASE OF BONE MARROW AND LIVER OF NEWBORN AUGUST AND WISTAR RATS AFTER ACUTE POSTNATAL HYPOXIA
par: L. I. Kolesnikova, et autres
Publié: (2014) -
Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release
par: Henry J. Bailey, et autres
Publié: (2020) -
Intraocular live male filarial Loa loa worm
par: André Omgbwa Eballe, et autres
Publié: (2009)